MTOR and Parkinson disease: Although alterations in both mTOR and TFEB expression have been previously reported in postmortem midbrains from PD patients (Wills et al., 2012; Decressac et al., 2013; Lan et al., 2017), the contribution of this pathway to PD pathogenesis could not be investigated in this model.